Clinical utility of a non-invasive urine test for risk assessing patients with no obvious benign cause of hematuria: a physician-patient real world data analysis

摘要: The non-invasive Cxbladder urine test system has demonstrated clinical utility in ruling out urothelial carcinoma (UC) patients with asymptomatic microscopic hematuria (AMH), suggesting that the number of invasive diagnostic tests, including cystoscopy, used this patient population may be reduced by testing prior to conducting a full urological work-up. aim study was demonstrate enhanced communicating objective information on decisions made individual physicians AMH. Three hundred ninety-six physician-patient were generated from twelve participant evaluating real world case notes same 33 presenting Each physician reviewed and recommended tests procedures based each patient’s referral data then re-evaluated their recommendation following disclosure result. Changes assessed were the total requested procedures, addition Triage Detect modalities. Physicians significant changes behavior for AMH when presented results, reduction cystoscopy individuals identified as having low probability UC. intensity investigation targeted increased, use high UC: urologists increased level for both procedures. outcome resulted risk UC receiving appropriate guideline-recommended tests. Patients who tested negative offered fewer significantly less This change results an utility, lower missed test-related harm incidents. potential resolution management, consider evaluation. led more procedure selection resource allocation benefit both healthcare systems.